This expanded approval is based on results from the pivotal FLOW phase 3b clinical trial, which demonstrated that once-weekly semaglutide led to a statistically significant 24% reduction in the risk of kidney disease progression, kidney failure, and cardiovascular death compared to placebo, when added to standard care
Stress and certain medications can also contribute
This is really exciting for us to see just further evidence of the benefits of these medications beyond weight loss. 19 Myth : Losing weight is the biggest benefit of GLP-1 medicines
When dosing children, be sure to consult a pediatric dosing calculator such as this one
Acknowledgments We thank LetPub (www.letpub.com.cn) for its linguistic assistance during the preparation of this manuscript
Peptide injections are useful for men and women in their 30s to 60s "who are noticing the effects of aging and want a regenerative boost without jumping straight to more invasive options," Kopelman says